<--- Back to Details
First PageDocument Content
Pharmacy / Mylan / Hydrochlorothiazide / Angiotensin II receptor antagonist / Tablet / Emtricitabine/tenofovir/efavirenz / Pharmacology / Dosage forms / Pharmaceutical sciences
Date: 2013-06-24 13:35:10
Pharmacy
Mylan
Hydrochlorothiazide
Angiotensin II receptor antagonist
Tablet
Emtricitabine/tenofovir/efavirenz
Pharmacology
Dosage forms
Pharmaceutical sciences

Updates to the Drug Benefit List

Add to Reading List

Source URL: hc-sc.gc.ca

Download Document from Source Website

File Size: 57,11 KB

Share Document on Facebook

Similar Documents

Information technology management / Management / Product development / Project management / Business process management / Visibility / Information technology / Economy / Project management office

RETAIL PHARMACY CASE STUDY Retail Pharmacy and Healthcare Distributor Case Study Global powerhouse gains visibility, strategic power and clarity with KeyedIn Projects SaaS solution

DocID: 1xVz3 - View Document

Health / Hepatotoxins / Medicinal chemistry / Pharmacy / Pharmacology / Dimensional Insight / Paracetamol / Health care

Case Study: WESTERN MARYLAND PHARMACY Improving Clinical Outcomes and Decreasing Acetaminophen Costs by 78% with Diver Platform

DocID: 1xTm3 - View Document

PDF Document

DocID: 1xQi5 - View Document

PDF Document

DocID: 1xNTr - View Document

PDF Document

DocID: 1xIyF - View Document